Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Nu Skin Enterprises, Inc.    NUS

NU SKIN ENTERPRISES, INC.

(NUS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Nu Skin Enterprises, Inc. : A good level to buy

share with twitter share with LinkedIn share with facebook
share via e-mail
07/11/2019 | 09:59am EDT
long trade
Stop-loss triggered
Entry price : 45.83$ | Target : 53.7$ | Stop-loss : 43.4$ | Potential : 17.17%
The medium term support area around 45.17 USD should allow Nu Skin Enterprises, Inc. shares to re-establish an upward trend in the short term.
Investors have an opportunity to buy the stock and target the $ 53.7.
Chart NU SKIN ENTERPRISES, INC.
Duration : Period :
Nu Skin Enterprises, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 11.61 for the current year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
  • The technical configuration over the long term remains negative on the weekly chart below the resistance level at 58.57 USD
Nu Skin Enterprises, Inc. : A good level to buy

David Meurisse
© Zonebourse.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2019 2 505 M
EBIT 2019 295 M
Net income 2019 184 M
Finance 2019 60,9 M
Yield 2019 3,69%
P/E ratio 2019 12,1x
P/E ratio 2020 11,3x
EV / Sales2019 0,86x
EV / Sales2020 0,85x
Capitalization 2 218 M
Upcoming event on NU SKIN ENTERPRISES, INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 47,86  $
Last Close Price 39,98  $
Spread / Highest target 75,1%
Spread / Average Target 19,7%
Spread / Lowest Target -7,45%
EPS Revisions
Managers
NameTitle
Ritch N. Wood Chief Executive Officer & Director
Ryan S. Napierski President
Steven J. Lund Executive Chairman
Mark H. Lawrence Chief Financial Officer & Executive Vice President
Joseph Y. Chang Chief Scientific Officer & EVP-Product Development
Sector and Competitors
1st jan.Capitalization (M$)
NU SKIN ENTERPRISES, INC.-33.16%2 274
PROCTER & GAMBLE COMPANY25.12%288 483
L'OREAL SA (ADR)--.--%156 072
UNILEVER PLC21.97%154 851
UNILEVER (NL)12.95%149 129
UNILEVER NV (ADR)11.82%149 129